Literature DB >> 22915031

Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization.

Mingkai Lin1, Yang Hu, Ying Chen, Kevin K Zhou, Ji Jin, Meili Zhu, Yun-Zheng Le, Jian Ge, Jian-Xing Ma.   

Abstract

PURPOSE: Hypoxia-inducible factor (HIF)-1 is a key oxygen sensor and is believed to play an important role in neovascularization (NV). The purpose of this study is to determine the role of retinal pigment epithelium (RPE)-derived HIF-1α on ocular NV.
METHODS: Conditional HIF-1α knockout (KO) mice were generated by crossing transgenic mice expressing Cre in the RPE with HIF-1α floxed mice, confirmed by immunohistochemistry, Western blot analysis, and fundus fluorescein angiography. The mice were used for the oxygen-induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV) models.
RESULTS: HIF-1α levels were significantly decreased in the RPE layer of ocular sections and in primary RPE cells from the HIF-1α KO mice. Under normal conditions, the HIF-1α KO mice exhibited no apparent abnormalities in retinal histology or visual function as shown by light microscopy and electroretinogram recording, respectively. The HIF-1α KO mice with OIR showed no significant difference from the wild-type (WT) mice in retinal levels of HIF-1α and VEGF as well as in the number of preretinal neovascular cells. In the laser-induced CNV model, however, the disruption of HIF-1α in the RPE attenuated the over expression of VEGF and the intercellular adhesion molecule 1 (ICAM-1), and reduced vascular leakage and CNV area.
CONCLUSIONS: RPE-derived HIF-1α plays a key role in CNV, but not in ischemia-induced retinal NV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22915031      PMCID: PMC4113187          DOI: 10.1167/iovs.11-8936

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  51 in total

Review 1.  Biochemistry of visual pigment regeneration: the Friedenwald lecture.

Authors:  J C Saari
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-02       Impact factor: 4.799

2.  Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats.

Authors:  D Zhang; P L Kaufman; G Gao; R A Saunders; J X Ma
Journal:  Diabetologia       Date:  2001-06       Impact factor: 10.122

3.  RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-/- mice.

Authors:  Ying Chen; Gennadiy Moiseyev; Yusuke Takahashi; Jian-Xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

4.  A conserved family of prolyl-4-hydroxylases that modify HIF.

Authors:  R K Bruick; S L McKnight
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

5.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

6.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

7.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

8.  VEGF is major stimulator in model of choroidal neovascularization.

Authors:  N Kwak; N Okamoto; J M Wood; P A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

Review 9.  Vascular endothelial growth factors and angiogenesis in eye disease.

Authors:  A N Witmer; G F J M Vrensen; C J F Van Noorden; R O Schlingemann
Journal:  Prog Retin Eye Res       Date:  2003-01       Impact factor: 21.198

Review 10.  Retinopathy of prematurity: molecular pathology and therapeutic strategies.

Authors:  Hadas Mechoulam; Eric A Pierce
Journal:  Am J Pharmacogenomics       Date:  2003
View more
  26 in total

1.  Retinal angiogenesis suppression through small molecule activation of p53.

Authors:  Sai H Chavala; Younghee Kim; Laura Tudisco; Valeria Cicatiello; Till Milde; Nagaraj Kerur; Nidia Claros; Susan Yanni; Victor H Guaiquil; William W Hauswirth; John S Penn; Shahin Rafii; Sandro De Falco; Thomas C Lee; Jayakrishna Ambati
Journal:  J Clin Invest       Date:  2013-09-09       Impact factor: 14.808

2.  Ocular Safety of Intravitreal Propranolol and Its Efficacy in Attenuation of Choroidal Neovascularization.

Authors:  Ramin Nourinia; Mozhgan Rezaei Kanavi; Amir Kaharkaboudi; Seyed Iman Taghavi; Seyed Javid Aldavood; Soesiawati R Darjatmoko; Shoujian Wang; Zafer Gurel; Jeremy A Lavine; Sare Safi; Hamid Ahmadieh; Narsis Daftarian; Nader Sheibani
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

3.  Anti-angiogenic Therapy for Retinal Disease.

Authors:  Yannis M Paulus; Akrit Sodhi
Journal:  Handb Exp Pharmacol       Date:  2017

4.  Hypoxia-Inducible Factor-1α in Rods Is Neuroprotective Following Retinal Detachment.

Authors:  Bing X Ross; Lin Jia; Dejuan Kong; Tiantian Wang; Jingyu Yao; Heather M Hager; Steven F Abcouwer; David N Zacks
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-10-03       Impact factor: 4.925

Review 5.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

6.  Dietary wolfberry upregulates carotenoid metabolic genes and enhances mitochondrial biogenesis in the retina of db/db diabetic mice.

Authors:  Huifeng Yu; Logan Wark; Hua Ji; Lloyd Willard; Yu Jaing; Jing Han; Hui He; Edlin Ortiz; Yunong Zhang; Denis M Medeiros; Dingbo Lin
Journal:  Mol Nutr Food Res       Date:  2013-03-15       Impact factor: 5.914

7.  Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization.

Authors:  Manas R Biswal; Howard M Prentice; George W Smith; Ping Zhu; Yao Tong; C Kathleen Dorey; Alfred S Lewin; Janet C Blanks
Journal:  J Mol Med (Berl)       Date:  2018-08-13       Impact factor: 4.599

8.  Puerarin suppresses hypoxia-induced vascular endothelial growth factor upregulation in human retinal pigmented epithelial cells by blocking JAK2/STAT3 pathway.

Authors:  Huixin Tang; Lingchun Kong; Yuqin Yang; Jingjing Li; Hong Zou
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

9.  Suppression of experimental choroidal neovascularization by curcumin in mice.

Authors:  Ping Xie; WeiWei Zhang; Songtao Yuan; Zhiqiang Chen; Qin Yang; DongQing Yuan; Feng Wang; QingHuai Liu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.

Authors:  Sidath E Liyanage; Alessandro Fantin; Pilar Villacampa; Clemens A Lange; Laura Denti; Enrico Cristante; Alexander J Smith; Robin R Ali; Ulrich F Luhmann; James W Bainbridge; Christiana Ruhrberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-24       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.